The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?-Reference-Cited by-同舟云学术

The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?

Published:2018-04-05 Issue:8 Volume:20 Page:1034-1043
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

Vanderbeek Alyssa M¹²,Rahman Rifaquat¹²,Fell Geoffrey³⁴²,Ventz Steffen²⁵,Chen Tianqi³⁴²,Redd Robert³⁴²,Parmigiani Giovanni³⁴²,Cloughesy Timothy F⁶,Wen Patrick Y⁷,Trippa Lorenzo²³⁴,Alexander Brian M¹⁷²

Affiliation:

1. Department of Radiation Oncology, Harvard Medical School, Boston, Massachusetts

2. Dana-Farber Program in Regulatory Science, Harvard Medical School, Boston, Massachusetts

3. Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

4. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

5. Department of Computer Science and Statistics, University of Rhode Island, Kingston, Rhode Island

6. University of California Los Angeles, Neuro-Oncology Program

7. Center for Neuro-Oncology, Harvard Medical School, Boston, Massachusetts

Funder

Burroughs Wellcome Fund

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/20/8/1034/27012808/noy027.pdf

Reference33 articles.

1. Adult glioblastoma;Alexander;J Clin Oncol,2017

2. Current status and perspectives of interventional clinical trials for glioblastoma—analysis of ClinicalTrials.gov;Cihoric;Radiat Oncol,2017

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Achievements of international rare cancers networks and consortia in the neuro-oncology field;Current Opinion in Oncology;2024-08-29

2. Dendritic cell vaccine for glioblastoma: an updated meta-analysis and trial sequential analysis;Journal of Neuro-Oncology;2024-08-21

3. Telehealth Utilization in Neuro-Oncology: Commentary on a Single Institution Experience After the COVID-19 Pandemic;Current Oncology Reports;2024-07-31

4. Glioblastoma Vaccines as Promising Immune-Therapeutics: Challenges and Current Status;Vaccines;2024-06-12

5. Assessment of therapeutic clinical trials for proximal humeral fractures;Clinics in Shoulder and Elbow;2024-06-01